CD226 and multiple sclerosis: The CD226-307Ser risk variant enhances interferon-γ (IFN-γ) signaling in CD8+ T cells via increased ERK1/2 and signal transducer and activator of transcription (STAT) 4 phosphorylation, contributing to chronic inflammation in conditions like multiple sclerosis [22].